Corporate finance capabilities are frequently underdeveloped in mid-market life sciences companies — not because leadership undervalues financial rigor, but because the urgency of commercial, scientific, and operational priorities consistently wins the resource allocation contest. Finance gets the tools and talent that are sufficient for reporting and compliance; the capabilities required for strategic financial decision-making are built much later than they should be.

This creates a specific and costly pattern: organizations make major capital allocation decisions — build vs. buy, market entry, M&A, equity structure — with analytical infrastructure that is not designed for those decisions. The decisions get made anyway, but with lower quality inputs and more reliance on intuition than the stakes warrant.

What Corporate Finance Capability Actually Means

Corporate finance capability is not accounting. It is the set of analytical and organizational tools that allow leadership to answer the capital allocation questions that determine the firm’s strategic trajectory.

At minimum, it includes: financial modeling adequate to evaluate strategic alternatives (not just report on actuals), scenario analysis capacity to understand how decisions perform across a range of possible futures, valuation methodology for evaluating investments and transactions, and treasury management sufficient to optimize working capital and funding structure.

In life sciences specifically, corporate finance capability also includes: cost-of-capital analysis relevant to the funding environment for life sciences at each stage, return modeling for R&D and product development investments that have long and uncertain payback periods, and partnership and licensing financial frameworks for evaluating deal structures that are common in the sector.

Why Mid-Market Companies Underinvest

The underinvestment pattern is consistent enough to have a structural explanation. Early-stage companies are resource-constrained and appropriately focus finance on cash management and investor reporting. Mid-stage companies add a layer of operational finance — budgeting, variance analysis, department-level P&L — as they scale. But the jump from operational finance to strategic finance capability is rarely made proactively; it tends to happen reactively, when a major transaction or capital raise exposes the gap.

By then, the company is building the analytical capability it needs while simultaneously trying to execute the transaction that requires it. The quality of both suffers.

Building Capability Ahead of Need

The investment logic for corporate finance capability is the same as for any other strategic capability: the cost of building it proactively is lower than the cost of improvising it under pressure.

The build sequence matters. The first capability to develop is financial modeling infrastructure — standardized, auditable models for planning and scenario analysis that can be adapted quickly to evaluate specific decisions. This is not a technology investment; it is a process and talent investment. A controller or FP&A lead with genuine modeling fluency is more valuable for this purpose than a sophisticated software platform with limited human capability behind it.

The second is valuation literacy at the senior leadership level. Leaders who can read and challenge a discounted cash flow model — who understand the assumptions driving a valuation and can identify where those assumptions are optimistic — make better capital allocation decisions than leaders who cannot. This is a development investment, not a hiring decision; it can often be built through selective external advisor relationships and structured internal exposure.

The third is decision frameworks specific to the types of capital allocation decisions the company faces regularly. A company that routinely evaluates build vs. buy decisions should have a standard analytical framework for that question. A company that regularly evaluates partnership deals should have a standard deal economics model. Building these frameworks proactively, rather than reconstructing analytical logic for each individual decision, reduces decision cycle time and improves consistency.

The Advisor Relationship Question

Mid-market companies that cannot yet justify a full-time CFO with deep corporate finance expertise often use investment banks, accounting firms, or strategy advisors to fill the gap. This works — up to a point. Advisors with transaction experience bring exactly the expertise required for specific capital events.

The risk is over-reliance: treating advisors as a substitute for internal capability rather than a complement to it. Advisors serve the transaction they are engaged for. They do not build the internal financial literacy that allows leadership to manage strategic capital allocation decisions between transactions. That literacy has to be built internally.

MKA Point of View

The companies we work with that navigate capital allocation decisions most effectively are not those with the most sophisticated financial tools. They are the ones where senior leadership has enough financial fluency to engage substantively with the analytical inputs to major decisions — to ask the right questions, identify the key assumptions, and understand what the numbers are and are not telling them.

That fluency is a corporate finance capability. It is worth investing in deliberately, well before the decisions that require it arrive.